<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95584">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01669356</url>
  </required_header>
  <id_info>
    <org_study_id>PNsupplESO</org_study_id>
    <secondary_id>Energy Supply Trial</secondary_id>
    <nct_id>NCT01669356</nct_id>
  </id_info>
  <brief_title>The Effect of Parenteral Nutrition Supplement on Esophagectomy Patients</brief_title>
  <official_title>The Effect of Parenteral Nutrition Supplement Versus Enteral Nutrition Alone on Nutrition Status After Esophagectomy: A Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <authority>China: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malnutrition is common in esophagus cancer patients, especially after surgery therapy.
      Whether parenteral supplement with enteral nutrtion is benificial for patients after
      esophagectomy is controversial, when compared with enteral nutrition alone. In this study,
      the investigators are to examine the effect of enteral nutrition supplemented with
      parenteral nutrtion on nutrition status after esophagectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>postoperative laboratory parameters changes for nutrition assessment compared to preoperation</measure>
    <time_frame>from one day before surgery to the 7th postoperative day</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>plasma albumin, prealbumin,  transferrin, retinaldehyde-binding protein, total lymphocytes counts</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative body composition change compared to preoperation measurement</measure>
    <time_frame>from one day before surgery to the 7th postoperative day</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>postoperative body composition is compared to preoperation,  bioelectrical impedance spectroscopy is  used for measurement of body composition</description>
  </primary_outcome>
  <other_outcome>
    <measure>complicatons incidence after surgery</measure>
    <time_frame>28 days after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>complications involve anastomotic leakage, incision infection, pneumonia, catherter-related blood stream infection, respiratory failure</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">95</enrollment>
  <condition>Esophagus Cancer</condition>
  <arm_group>
    <arm_group_label>PN supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Parenteral supplement with enteral nutrition for patients after esophagectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EN alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Enteral nutrition alone for patients after esophagectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Parenteral supplement with enteral nutrition for patients after esophagectomy</intervention_name>
    <arm_group_label>PN supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enteral Nutrition alone for patients after esophagectomy</intervention_name>
    <arm_group_label>EN alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of esophagus cancer

          -  Undergo esophagectomy

          -  Nasoenteral tube is placed or surgical jejunostomy is performed

        Exclusion Criteria:

          -  Contraindication for enteral nutrition or parenteral nutrition

          -  Malnutrition before surgery ( BMI &gt; 30 or &lt; 18.5)

          -  Hepatic dysfunction preoperatively

          -  Renal dysfunction preoperatively

          -  Infection before surgery

          -  Usage of corticosteroid before surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zhongshan Hospital Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 30, 2014</lastchanged_date>
  <firstreceived_date>August 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>malnutrition</keyword>
  <keyword>parenteral supplement</keyword>
  <keyword>rest metabolic rate</keyword>
  <keyword>postoperative complications</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
